Antitumoral Effects of Melissa officinalis on Breast Cancer in Vitro and in Vivo
Caspase 7
Plant Extracts
Mammary Neoplasms, Experimental
Apoptosis
Breast Neoplasms
Antineoplastic Agents, Phytogenic
Melissa
Rats
3. Good health
03 medical and health sciences
breast cancer
Ki-67 Antigen
0302 clinical medicine
Melissa officinalis
antitumoral effects
Cell Line, Tumor
616
Animals
Humans
Female
Cell Proliferation
Phytotherapy
DOI:
10.7314/apjcp.2012.13.6.2765
Publication Date:
2012-10-11T12:10:36Z
AUTHORS (12)
ABSTRACT
There is a long standing interest in the identification of medicinal plants and derived natural products for developing cancer therapeutics. Here we investigated the antiproliferative properties of Melissa officinalis (MO) from Turkey on breast cancer.MO extracts were studied for cytotoxicity against breast cancer cell lines (MCF-7, MDA-MB-468 and MDA-MB-231). In vitro apoptosis studies were performed by annexin V staining and flow cytometry analyses. Immunohistochemistry for Ki-67 and caspase 7 in the tumoral tissue sections of DMBA-induced mammary tumors in rats was also performed, along with TUNEL assays to detect apoptotic cells. In vivo anticancer activity testing was carried out with reference to inhibition of growth of DMBA induced mammary tumors in rats.MO showed cytotoxicity against three cancer cell lines, inducing increase in Annexin-positive cells. Expression of caspase-7 protein and TUNEL positive cells were much higher in rats treated by MO, compared with the untreated control group, while expression of Ki-67 was decreased. Furthermore, in vivo studies showed that mean tumor volume inhibition ratio in MO treated group was 40% compared with the untreated rats.These results indicated that MO extrcts have antitumoral potential against breast cancer.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (14)
CITATIONS (33)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....